Serological proteome analysis to identify systemic candidiasis patients in the intensive care unit: Analytical, diagnostic and prognostic validation of anti-Candida enolase antibodies on quantitative clinical platforms

Proteomics - Clinical Applications

Volumn 2, Issue 4, 2008, Pages 596-618

  Pitarch, Aida ^a   Jiménez, Antonio ^b   Nombela, César ^a   Gill, Concha ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Diagnostic accuracy; Enolase; Sensitivity and specificity; Systemic candidiasis

Indexed keywords

ENOLASE ANTIBODY; FUNGUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEOME; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; CANDIDA ALBICANS; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNGUS CULTURE; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTOPLAST; QUANTITATIVE ANALYSIS; SERODIAGNOSIS; SEROLOGICAL PROTEOME ANALYSIS; VALIDATION STUDY; WESTERN BLOTTING;

CANDIDA; CANDIDA ALBICANS;

EID: 42449107008     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780039     Document Type: Article

References (73)

1. Pappas, P. G., Infect Invasive candidiasis. Dis. Clin. North Am. 2006, 20, 485-606.
2. Jarvis, W. R., Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 1995, 20, 1526-1530.
3. Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect. Control Hosp. Epidemiol. 2000, 21, 510-615.
4. Ostrosky-Zeichner, L., Pappas, P. G., Invasive candidiasis in the intensive care unit. Crit. Care Med. 2006, 34, 857-863.
5. Bassetti, M., Righi, E., Tumbarello, M., Di Biagio, A. et al., Candida infections in the intensive care unit: Epidemiology, risk factors and therapeutic strategies. Expert Rev. Anti Infect. Ther. 2006, 4, 875-885.
6. Sims, C. R., Ostrosky-Zeichner, L., Rex, J. H., Invasive candidiasis in immunocompromised hospitalized patients. Arch. Med. Res. 2005, 36, 660-671.
7. Eggimann, P., Garbino, J., Pittet, D., Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 2003, 3, 685-702.
8. Uzun, O. and Anaissie, E. J., Predictors of outcome in cancer patients with candidemia. Ann. Oncol. 2000, 11, 1517-1521.
9. Falagas, M. E., Apostolou, K. E., Pappas, V. D., Attributable mortality of candidemia: A systematic review of matched cohort and case-control studies. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25, 419-425.
10. Leleu, G., Aegerter, P., Guidet, B., Systemic candidiasis in intensive care units: A multicenter, matched-cohort study. J. Crit. Care 2002, 17, 168-175.
11. Wilson, L. S., Reyes, C. M., Stolpman, M., Speckman, J. et al., The direct cost and incidence of systemic fungal infections. Value Health 2002, 25, 26-34.
12. Horvath, L. L., Hospenthal, D. R., Murray, C. K., Dooley, D. P., Detection of simulated candidemia by the BACTEC 9240 system with plus aerobic/F and anaerobic/F blood culture bottles. J. Clin. Microbiol. 2003, 41, 4714-4717.
13. Ellepola, A. N., Morrison, C. J., Laboratory diagnosis of invasive candidiasis. J. Microbiol. 2005, 43, 65-84.
14. Dea-Ayuela, M. A., Ubeira, F. M., Pitarch, A., Gil, C. et al., A comparison of antigenic peptides in muscle larvae of several Trichinella species by two-dimensional western-blot analysis with monoclonal antibodies. Parasite 2001, 8, S117-S119.
15. Kositanont, U., Saetun, P., Krittanai, C., Doungchawee, G. et al., Application of immunoproteomics to leptospirosis: Towards clinical diagnostics and vaccine discovery. Proteomics Clin. Appl. 2007, 1, 400-409.
16. Alvarez-Garcia, G., Pitarch, A., Zaballos, A., Fernández-García, A. et al., The NcGRA7 gene encodes the immunodominant 17-kDa antigen of Neospora caninum. Parasitology 2007, 134, 41-50.
17. Pitarch, A., Jimenez, A., Nombela, C., Gil, C., Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses. Mol. Cell. Proteomics 2006, 5, 79-96.
18. Pitarch, A., Abian, J., Carrascal, M., Sanchez, M. et al., Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 2004, 4, 3084-3106.
19. Pitarch, A., Pardo, M., Jimenez, A., Pla, J. et al., Two-dimensional gel electrophoresis as analytical tool for identifying Candida albicans immunogenic proteins. Electrophoresis 1999, 20, 1001-1010.
20. Pitarch, A., Nombela, C., Gil, C., Contributions of proteomics to diagnosis, treatment, and prevention of candidiasis. Methods Biochem. Anal. 2006, 49, 331-361.
21. Thomas, D. P., Pitarch, A., Monteoliva, L., Gil, C., Lopez-Ribot, J. L., Proteomics to study Candida albicans biology and pathogenicity. Infect. Disord. Drug Targets 2006, 6, 335-341.
22. Xiao, Z-Q., Chen, Y., Yi, B., Li, M-Y. et al., Identification of nasopharyngeal carcinoma antigens that induce humoral immune response by proteomic analysis. Proteomics Clin. Appl. 2007, 1, 688-698.
23. He, Y., Wu, Y., Mou, Z., Li, W. et al., Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer. Proteomics Clin. Appl. 2007, 1, 336-342.
24. Cho, E-H., Kim, M-R., Kim, H-J., Lee, D-Y. et al., The discovery of biomarkers for type 2 diabetic nephropathy by serum proteome analysis. Proteomics Clin. Appl. 2007, 1, 352-361.
25. Nakamura, M., Kuramasu, A., Nakashima, I., Fujihara, K., Itoyama, Y., Candidate antigens specifically detected by cerebrospinal fluid-IgG in oligoclonal IgG bands-positive multiple sclerosis patients. Proteomics Clin. Appl. 2007, 1, 681-687.
26. Serada, S., Fujimoto, M., Takahashi, T., He, P. et al., Proteomic analysis of autoantigens associated with systemic lupus erythematosus: Anti-aldolase A antibody as a potential marker of lupus nephritis. Proteomics Clin. Appl. 2007, 1, 185-191.
27. Petersen, A., Dresselhaus, T., Grobe, K., Becker, W-M. et al., Proteome analysis of maize pollen for allergy-relevant components. Proteomics 2006, 6, 6317-6325.
28. Pitarch, A., Nombela, C., Gil, C., Reliability of antibodies to Candida methionine synthase for diagnosis, prognosis and risk stratification in systemic candidiasis: A generic strategy for the prototype development phase of proteomic markers. Proteomics Clin. Appl. 2007, 1, 1221-1242.
29. Pitarch, A., Nombela, C., Gil, C., Proteomic profiling of serological response to Candida albicans during host-commensal and host-pathogen interactions. Methods Mol. Biol., 470, ch. 26.
30. Pitarch, A., Nombela, C., Gil, C., Identification of the Candida albicans immunome exposed during systemic infection by mass spectrometry. Methods Mol. Biol., 470, ch. 15.
31. Pitarch, A., Sanchez, M., Nombela, C., Gil, C., Analysis of the Candida albicans proteome. II. Protein information technology on the Net (update 2002). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 787, 129-148.
32. Valdes, I., Pitarch, A., Gil, C., Bermudez, A. et al., Novel procedure for the identification of proteins by mass finger-printing combining two-dimensional electrophoresis with fluorescent SYPRO red staining. J. Mass Spectrom. 2000, 35, 672-682.
33. Pardo, M., Ward, M., Pitarch, A., Sanchez, M. et al., Cross-species identification of novel Candida albicans immunogenic proteins by combination of two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Electrophoresis 2000, 21, 2651-2659.
34. Pitarch, A., Sanchez, M., Nombela, C., Gil, C., Sequential fractionation and two-dimensional gel analysis unravels the complexity of the dimorphic fungus Candida albicans cell wall proteome. Mol. Cell. Proteomics 2002, 1, 967-982.
35. Eisen, M. B., Spellman, P. T., Brown, P. O., Botstein, D., Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 1998, 95, 14863-14868.
36. Kluger, Y., Tuck, D. P., Chang, J. T., Nakayama, Y. et al., Lineage specificity of gene expression patterns. Proc. Natl. Acad. Sd. USA 2004, 101, 6508-6513.
37. Hanley, J. A., McNeil, B. J., A method of comparing the areas under receiver operating characterisfic curves derived from the same cases. Radiology 1983, 148, 839-843.
38. Pitarch, A., Sanchez, M., Nombela, C., Gil, C., Analysis of the Candida albicans proteome. I. Strategies and applications. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 787, 101-128.
39. Pitarch, A., Nombela, C., Gil, C., in: San-Blas, G., Calderone, R. (Eds)., Pathogenic Fungi: Insights in Molecular Biology, Caister Academic Press, Norfolk, UK 2008, pp. 103-142.
40. Thomas, D. P., Viudes, A., Monteagudo, C., Lazzell et al., A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated vandidiasis. Proteomics 2006, 6, 6033-6041.
41. Fernandez-Arenas, E., Molero, G., Nombela, C., Diez-Orejas, R., Gil, C., Low virulent strains of Candida albicans Unravelling the antigens for a future vaccine. Proteomics 2004, 4, 3007-3020.
42. Martinez, J. P., Gil, M. L., Lopez-Ribot, J. L., Chaffin, W. L., Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin. Microbiol. Rev. 1998, 11, 121-141.
43. Pitarch, A., Diez-Orejas, R., Molero, G., Pardo, M. et al., Analysis of the serologic response to systemic Candida albicans infection in a murine model. Proteomics 2001, 1, 550-559.
44. Mitsutake, K., Kohno, S., Miyazaki, T., Miyazaki, H. et al., Detection of Candida enolase antibody in patients with candidiasis. J. Clin. Lab. Anal. 1994, 8, 207-210.
45. van Deventer, A. J., van Vliet, H. J., Hop, W. C., Goessens, W. H., Diagnostic value of anti-Candida enolase antibodies. J. Clin. Microbiol. 1994, 32, 17-23.
46. Lain, A., Moragues, M., Garcia-Ruiz, J. C., Mendoza, J. et al., Evaluation of a novel enzyme-linked immunasorbent assay to detect immunoglobulin G antibody to enolase for sero-diagnosis of invasive candidiasis. Clin. Vaccine Immunol. 2007, 14, 318-319.
47. Kustrzeba-Wójcicka, I., Golczak, M., Enolase from Candida albicans-purification and characterization. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2000, 126, 109-120.
48. Jong, A. Y., Chen, S. H., Stins, M. F., Kim, K. S. et al., Binding of Candida albicans enolase to plasmin(ogen) results in enhanced invasion of human brain microvascular endothelial cells. J. Med. Microbiol. 2003, 52, 615-622.
49. Pitarch, A., Nombela, C., Gil, C., Candida albicans biology and pathogenicity: insights from proteomics. Methods Biochem. Anal. 2006, 49, 285-330.
50. Strockbine, N. A., Largen, M. T., Zweibel, S. M., Buckley, H. R., Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera. Infect. Immun. 1984, 43, 715-721.
51. Ishiguro, A., Homma, M., Torii, S., Tanaka, K., Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera. Infect. Immun. 1992, 60, 1550-1557.
52. Angiolella, L., Facchin, M., Stringaro, A., Maras, B. et al., Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics. J. Infect. Dis. 1996, 173, 684-690.
53. Chaffin, W. L., Lopez-Ribot, J. L., Casanova, M., Gozalbo, D., Martinez, J. P., Cell wall and secreted proteins of Candida albicans: Identification, function, and expression. Microbiol. Mol. Biol. Rev. 1998, 62, 130-180.
54. Sundstrom, P., and Aliaga, G. R., A subset of proteins found in culture supernatants of Candida albicans includes the abundant, immunodominant, glycolytic enzyme enolase. J. Infect. Dis. 1994, 169, 452-456.
55. Walsh, T. J., Hathorn, J. W., Sobel, J. D., Merz, W. G. et al., Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N. Engl. J. Med. 1991, 324, 1026-1031.
56. Mischak, H., Apweiler, R., Banks, R. E., Conaway, M. et al., Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin. Appl. 2007, 1, 148-156.
57. Ferguson, R. E., Hochstrasser, D. F., Banks, R. E., Impact of preanalytical variables on the analysis of biological fluids in proteomic studies. Proteomics Clin. Appl. 2007, 1, 739-746.
58. Pollard, H. B., Srivastava, M., Eidelman, O., Joz Wik, C. et al., Protein microarray platforms for clinical proteomics. Proteomics Clin. Appl. 2007, 1, 934-952.
59. Bromuro, C., La Valle, R., Sandini, S., Urbani, F. et al., A 70-kilodaltan recombinant heat shock protein of Candida albicans is highly immunogenic and enhances systemic murine candidiasis. Infect. Immun. 1998, 66, 2154-2162.
60. Sandini, S., Melchionna, H., Arancia, S., Gomez, M. J., La Valle, R., Generation of a highly immunogenic recombinant enolase of the human opportunistic pathogen Candida albicans. Biotechnol. Appl. Biochem. 1999, 29, 223-227.
61. Haese, A., Vaisanen, V., Finlay, J. A., Pettersson, K. et al., Standardization of two immunoassays for human glandular kallikrein 2. Clin. Chem. 2003, 49, 601-610.
62. Meschede, W., Zumbach, K., Braspenning, J., Scheffner, M. et al., Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J. Clin. Microbiol. 1998, 36, 475-480.
63. Ehrlich, J. R., Caiazzo, R. J., Qui, W. L., Tassinari, O. W. et al., A native antigen "reverse capture" microarray platform for autoantibody profiling of prostate cancer sera. Proteomics Clin. Appl. 2007, 1, 476-485.
64. Sehr, P., Zumbach, K., Pawlita, M., A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: Validation for HPV serology. J. Immunol. Methods 2001, 253, 153-162.
65. Darst, S. A., Robertson, C. R., Berzofsky, J. A., Adsorption of the protein antigen myoglobin affects the binding of conformation-specific monoclonal antibodies. Biophys. J. 1988, 53, 533-539.
66. Goldberg, M. E., Djavadi-Ohaniance, L., Methods for measurement of antibody/antigen affinity based on ELISA and RIA. Curr. Opin. Immunol. 1993, 5, 278-281.
67. Butler, J. E., Ni, L., Brown, W. R., Joshi, K. S. et al., The immunochemistry of sandwich ELISAs-VI: Greater than 90% of monoclonal and 75% of polyclonal anti-fluorescyl capture antibodies (CAbs) are denatured by passive adsorption. Mol. Immunol. 1993, 30, 1165-1175.
68. Kinloch, A., Tatzer, V., Wait, R., Peston, D. et al., Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res. Ther. 2005, 7, 1421-1429.
69. Pal-Bhowmick, I., Vora, H. K., Jarori, G., Sub-cellular localization and post-translational modifications of the Plasmodium yoelii enolase suggest moonlighting functions. Malar. J. 2007, 6, 45.
70. Lijmer, J. G., Mol, B. W., Heisterkamp, S., Bonsel, G. J. et al., Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999, 282, 1061-1066.
71. Garcia-Ruiz, J. C., del Carmen, A. M., Regulez, P., Quindos, G. et al., Detection of antibodies to Candida albicans germ tubes for diagnosis and therapeutic monitoring of invasive candidiasis in patients with hematologic malignancies. J. Clin. Microbiol. 1997, 35, 3284-3287.
72. Brennan, P., Silman, A., Statistical methods for assessing observer variability in clinical measures. BMJ 1992, 304, 1491-1494.
73. Rutjes, A. W. S., Reitsma, J.B., Vandenbroucke, J. P., Glas, A. S., Bossuyt, P. M. M., Case-control and two-gate designs in diagnostic accuracy studies. Clin. Chem. 2005, 51, 1335-1341.